DOHH
MOLECULAR TARGETdeoxyhypusine hydroxylase
DOHH (deoxyhypusine hydroxylase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting DOHH
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | deferiprone | 3.81 | 44 |
| 2 | ciclopirox | 3.18 | 23 |
| 3 | dipyridyl | 2.89 | 17 |
| 4 | l mimosine | 2.30 | 9 |
| 5 | Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as | 0.69 | 1 |
| 6 | Mimosine 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. | 0.69 | 1 |
About DOHH as a Drug Target
DOHH (deoxyhypusine hydroxylase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented DOHH interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
DOHH inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.